Fig. 2From: Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database studyCumulative incidence in heart failure hospitalization (a), acute coronary syndrome (b), ischemic stroke (c), and one sinus survival in all-cause mortality (d) in T2DM patients prescribed with either SGLT2i or metformin as first-line treatmentBack to article page